Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation

Launched by OHSU KNIGHT CANCER INSTITUTE · Jul 9, 2021

Keywords

ClinConnect Summary

This study tests whether adding an electronic Quitline referral system in community health centers helps more patients who use tobacco get help to quit. Clinics are randomly assigned to two approaches: Arm I uses the Quitline eReferral with informational materials, while Arm II adds enhanced staff training, booster sessions, and monthly feedback (enhanced academic detailing). Over about 24 months, researchers will look at how often eReferrals are offered and accepted, how many patients enroll in Quitline services, whether cessation medications are ordered, whether in-office counseling is provided, and whether patients report quitting tobacco.

Who can participate? Adults 18 and older who currently use tobacco and receive care at participating Oregon clinics that use the OCHIN Epic electronic health record. Clinics must agree to be randomized and appoint a clinic champion and a manager to help run the program. If you’re a patient in one of these clinics, you may be identified as a current tobacco user and offered an electronic Quitline referral, with potential counseling or medication orders captured in your health record. The study also looks at costs and whether the approach is cost-effective. Results are not yet available; the trial runs through 2026.

Gender

ALL

Eligibility criteria

• Study Clinic Inclusion Criteria:
• • In Oregon
• • On the OCHIN Epic EHR for \>= 1 year
• • Willing to be randomized to the intervention or comparison condition
• • Willing to recruit a provider to serve as a clinic champion (to share monthly performance audit and feedback at all-staff meetings, determine desired content of booster sessions with clinic team members, and complete a survey at the completion of the intervention period) and a clinic manager to coordinate training and booster sessions
• Study Patient Inclusion Criteria:
• • Adult patients (\>= 18 years of age)
• • Identified as current tobacco users during \>= 1 ambulatory and/or telehealth visit to one of the eligible study clinics over the 24-month study period